It’s the brainchild of corporate anxiety and it wastes everyone’s time. A silent productivity killer is operating in every ...

NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to advance cancer therapy ...

American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd ...

Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in ...

AM Best will speak and exhibit at RISKWORLD--the RIMS 2026 Annual Conference and Exhibition--with sessions that will focus on the state of the global reinsurance market and the impact of social ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that ...

The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced two poster ...

McKinsey & Company has been creating presentations and reports for nearly 100 years. As one of the most prestigious ...

Lead author Patricia LoRusso, DO, PhD (hc), FAACR will present an updated data cut from the late breaking abstract on Tuesday, April 21, 2026 at 2:30 – 4:30 pm Pacific Standard Time (PST). The ...